Free Trial
OTCMKTS:PPMD

Protide Pharmaceuticals (PPMD) Stock Price, News & Analysis

→ What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad)
Free PPMD Stock Alerts
$0.22
0.00 (0.00%)
(As of 10/21/2022)
Compare
Today's Range
$0.22
▼
$0.22
50-Day Range
$0.22
▼
$0.22
52-Week Range
$0.02
▼
$0.48
Volume
N/A
Average Volume
6,570 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About Protide Pharmaceuticals

Protide Pharmaceuticals, Inc. discovers, develops, and commercializes technologies and processes in the areas of clinical cell therapy, regenerative medicine, transfusion medicine, cell engineering, and transplantation in the United States and internationally. It offers serum reducers, cell culture and processing products, stem cell cryopreservatives, and stem cell and regenerative research products. The company is based in Lake Zurich, Illinois.

PPMD Stock Price History

PPMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive PPMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Protide Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
6/01/2024
Fiscal Year End
8/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:PPMD
CUSIP
N/A
CIK
N/A
Web
www.protidepharma.com
Phone
(847) 726-3100
Fax
651-730-8900
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.20
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Milo R. Polovina (Age 66)
    Chairman, CEO, Pres, Principal Financial Officer, Sec. and Treasurer

Key Competitors

View All Competitors

PPMD Stock Analysis - Frequently Asked Questions

How have PPMD shares performed in 2024?

Protide Pharmaceuticals' stock was trading at $0.22 at the start of the year. Since then, PPMD stock has increased by 0.0% and is now trading at $0.22.
View the best growth stocks for 2024 here.

How do I buy shares of Protide Pharmaceuticals?

Shares of PPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PPMD) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners
Dems have chosen Biden replacement?
Paradigm Press
Trump’s Gift Could Unleash $51 Billion in New Wealth
Wealthpin Pro
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
Bill Clinton Backing Biden Replacement???
The Freeport Society
Nvidia has Apple and Microsoft within striking range
Weiss Ratings
“This will be one of the biggest revolutions ever.” - NVIDIA CEO
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders